Tag: entrepreneurs
-
Clinical Trial Begins for Liver Dialysis Device
A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option.
-
Start-Up Building Mobile Apps Combining DNA, Lifestyle
A new enterprise in California is creating smartphone apps that provide lifestyle advice based on DNA analysis and activity tracking.
-
Start-Up Offering Precise Heart Rhythm Diagnostic
A one year-old company in New York City is developing a device that assesses the severity of heart rhythm problems to prescribe a more precise course of treatment.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.
-
Battery-Free Cell Phone Demonstrated
A computer science and engineering team demonstrated a prototype cell phone that sends and receives calls, but operates with power from ambient light and radio signals.
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
Chip Device Quickly Detects Sepsis in Blood
An engineering team designed a lab-on-a-chip device that in tests with hospital patients shows it can find signs of sepsis in a drop of blood in about 30 minutes.
-
Start-Up to Offer Neuro Disorder Speech Analytics App
A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
$300M Fund to Back European Life Science Companies
A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development.